NCT06484426Completed
Goal Attainment Scaling (GAS) Sub-Study
The Goal Attainment Scaling in Down Syndrome-associated Alzheimer's Disease (DS-AD) Sub-study
Source: ClinicalTrials.gov · Last updated 3 Jul 2024
Brief summary (registry, in English)
This is an optional sub-study that will enroll participants from LIFE-DSR parent protocol. The aim is to assess change over 16 months in individuals with Down syndrome through individualized goals set by their caregivers. This sub-study also aims to assess the feasibility of Goal Attainment Scaling in the DS-AD population.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 46 (actual)
- First submitted
- 20 Mar 2024
- Start date
- 30 Jun 2021
- Primary completion date
- 29 Feb 2024
- Lead sponsor
- LuMind IDSC Foundation
- Diseases
- Alzheimer disease
- NCT number
- NCT06484426
What you commit to
- Study type: Observational
- Participants enrolled: 46
- From 30 Jun 2021 to the primary completion date, 29 Feb 2024
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to complete trial procedures or adhere to the schedule of study assessments, in the opinion of the site PI.
Who the study is looking for
- The participant with DS and caregiver must be currently enrolled in the LIFE-DSR parent protocol.
- The participant with DS must be age 35 years or older.
- Both the participant with DS, or LAR, and their caregiver must be able to understand and be willing to sign written informed consent.
- In the opinion of the Investigator, a participant's caregiver must have frequent interaction with the participant on a regular basis, agree to participate in clinic and remote visits, be able to provide accurate responses to questions about the participant with DS, and be capable of facilitating participation in the study visits.
- Participant with DS and caregiver must be capable of reliably completing all study assessments at each time-point.
- The caregiver must be able to converse in English.
Age in the registry: 35 years to - · Sex: All
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kennedy Krieger Institute Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Case Western Reserve University School of Medicine Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
| Advocate Health Coordinator of this site? Confirm its status | Park Ridge | United States | Unknown status |
| University of California San Diego Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.